Acridorex
Amphetamine
- None
- N-[2-(9-acridinyl)ethyl]-1-phenyl-2-propanamine
- 47487-22-9
- 297931
- 263084
- 7SGV5HQH8B
- Interactive image
- CC(Cc1ccccc1)NCCc2c3ccccc3nc4c2cccc4
InChI
- InChI=1S/C24H24N2/c1-18(17-19-9-3-2-4-10-19)25-16-15-20-21-11-5-7-13-23(21)26-24-14-8-6-12-22(20)24/h2-14,18,25H,15-17H2,1H3
- Key:SZSWKYIWACGNDZ-UHFFFAOYSA-N
Acridorex (INN; BS 7573a) is an amphetamine which was investigated as an anorectic but does not appear to have ever been marketed.[1][2]
References
- v
- t
- e
Antiobesity agents/Anorectics (A08)
antagonists
glucagon agonists
receptor agonists
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e